Low-dose ciclosporin therapy of erythrodermic psoriasis

Abstract

Psoriasis is a chronic, recurrent inflammatory skin disease which affects around 2% of the population and is characterized by erythematous and scaly macules and papules of greatly varying degree of involvement. Ciclosporin (Cs) is a therapeutic agent rarely used in the treatment of erythrodermic psoriasis as a monotherapy [1].

Keywords

• Low-dose ciclosporin therapy
• psoriasis
• monotherapy